Venclexta / Venclyxto (venetoclax) 100 mg film-coated tablets, 112 tablets — original (AbbVie, Ireland) Treatment of lymphocytic leukemia. Targeted cancer therapy. Drug delivery from Europe, strict storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

The website offers a generic version in 120 tablets. Type venclyxto in the search bar. 

Indications

Venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic (lymphoid) leukemia (CLL).

Venclyxto in combination with rituximab is indicated for the treatment of adult patients with CLL who have received at least one prior line of therapy.

Venclyxto® is indicated as monotherapy in CLL:

- in patients with a 17p deletion or a TP53 mutation who are ineligible for or have failed treatment with a B-cell receptor inhibitor;

- in patients without a 17p deletion or TP53 mutation, if Chemotherapy and B-cell receptor inhibitor therapy were ineffective.

Venclixto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy.